newsfilter
← Latest News
GlobeNewswire·

Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases